The Ansuvimab-Zykl for Injection, cataloged under National Stock Number 6505-01-716-1528, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-716-1528 |
| Primary Part Number | NDC80673-0777-01 |
| Item Name | Ansuvimab-Zykl for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC80673-0777-01 PRIMARY | Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM239488 | 5/1 Secondary reference Defense Medical Standardization Board |
| EBANGO | 5/1 Secondary reference Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense |
| 1659561 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-716-1528 is a Ansuvimab-Zykl for Injection, manufactured by Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-716-1528 has 1 manufacturer part number on file: NDC80673-0777-01 (Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense).
Key specifications for NDC80673-0777-01: Special Features: ANSUVIMAB-ZYKL FOR INJECTION(PF), 400MG LYOPHILIZED POWDER IN SINGLE-DOSE VIALS. PACKAGE CONTAINS 36 VIALS. FOR INTRAVENOUS USE. RECONSTITUTE AND DILUTE PRIOR TO ADMINISTRATION. INDICATED FOR THE TREATMENT OF INFECTION CAUSED BY ZAIRE EBOLA VIRUS. STORE REFRIGERATED AT 2 C TO 8 C (36 F TO 46 F) IN THE ORIGINAL CARTON TO PROTECT FROM LIGHT. DO NOT FREEZE. DO NOT SHAKE.; Part Name Assigned by Controlling Agency: ANSUVIMAB-ZYKL FOR INJECTION VIAL 400MG LYOPHILIZED POWDER 36EA. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.